img

Global Oral Insulin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Insulin Market Insights, Forecast to 2034

The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
Global Oral Insulin market is expected to reach to US$ 564 million in 2024, with a positive growth of %, compared with US$ 536 million in 2022. Backed with the increasing demand from downstream industries, Oral Insulin industry is evaluated to reach US$ 782.1 million in 2029. The CAGR will be 5.6% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oral Insulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Insulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
Segment by Type
Type 1 Diabetes
Type 2 Diabetes

Segment by Application


Female
Male

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral Insulin plant distribution, commercial date of Oral Insulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Oral Insulin introduction, etc. Oral Insulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Oral Insulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Oral Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Oral Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.3 Market by Application
1.3.1 Global Oral Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Female
1.3.3 Male
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral Insulin Sales Estimates and Forecasts 2018-2029
2.2 Global Oral Insulin Revenue by Region
2.2.1 Global Oral Insulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oral Insulin Revenue by Region (2018-2024)
2.2.3 Global Oral Insulin Revenue by Region (2024-2029)
2.2.4 Global Oral Insulin Revenue Market Share by Region (2018-2029)
2.3 Global Oral Insulin Sales Estimates and Forecasts 2018-2029
2.4 Global Oral Insulin Sales by Region
2.4.1 Global Oral Insulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oral Insulin Sales by Region (2018-2024)
2.4.3 Global Oral Insulin Sales by Region (2024-2029)
2.4.4 Global Oral Insulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oral Insulin Sales by Manufacturers
3.1.1 Global Oral Insulin Sales by Manufacturers (2018-2024)
3.1.2 Global Oral Insulin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Insulin in 2022
3.2 Global Oral Insulin Revenue by Manufacturers
3.2.1 Global Oral Insulin Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral Insulin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral Insulin Revenue in 2022
3.3 Global Key Players of Oral Insulin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oral Insulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Oral Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Insulin Sales by Type
4.1.1 Global Oral Insulin Historical Sales by Type (2018-2024)
4.1.2 Global Oral Insulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Oral Insulin Sales Market Share by Type (2018-2029)
4.2 Global Oral Insulin Revenue by Type
4.2.1 Global Oral Insulin Historical Revenue by Type (2018-2024)
4.2.2 Global Oral Insulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oral Insulin Revenue Market Share by Type (2018-2029)
4.3 Global Oral Insulin Price by Type
4.3.1 Global Oral Insulin Price by Type (2018-2024)
4.3.2 Global Oral Insulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oral Insulin Sales by Application
5.1.1 Global Oral Insulin Historical Sales by Application (2018-2024)
5.1.2 Global Oral Insulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Oral Insulin Sales Market Share by Application (2018-2029)
5.2 Global Oral Insulin Revenue by Application
5.2.1 Global Oral Insulin Historical Revenue by Application (2018-2024)
5.2.2 Global Oral Insulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oral Insulin Revenue Market Share by Application (2018-2029)
5.3 Global Oral Insulin Price by Application
5.3.1 Global Oral Insulin Price by Application (2018-2024)
5.3.2 Global Oral Insulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oral Insulin Market Size by Type
6.1.1 US & Canada Oral Insulin Sales by Type (2018-2029)
6.1.2 US & Canada Oral Insulin Revenue by Type (2018-2029)
6.2 US & Canada Oral Insulin Market Size by Application
6.2.1 US & Canada Oral Insulin Sales by Application (2018-2029)
6.2.2 US & Canada Oral Insulin Revenue by Application (2018-2029)
6.3 US & Canada Oral Insulin Market Size by Country
6.3.1 US & Canada Oral Insulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oral Insulin Sales by Country (2018-2029)
6.3.3 US & Canada Oral Insulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oral Insulin Market Size by Type
7.1.1 Europe Oral Insulin Sales by Type (2018-2029)
7.1.2 Europe Oral Insulin Revenue by Type (2018-2029)
7.2 Europe Oral Insulin Market Size by Application
7.2.1 Europe Oral Insulin Sales by Application (2018-2029)
7.2.2 Europe Oral Insulin Revenue by Application (2018-2029)
7.3 Europe Oral Insulin Market Size by Country
7.3.1 Europe Oral Insulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oral Insulin Sales by Country (2018-2029)
7.3.3 Europe Oral Insulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oral Insulin Market Size
8.1.1 China Oral Insulin Sales (2018-2029)
8.1.2 China Oral Insulin Revenue (2018-2029)
8.2 China Oral Insulin Market Size by Application
8.2.1 China Oral Insulin Sales by Application (2018-2029)
8.2.2 China Oral Insulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Insulin Market Size by Type
9.1.1 Asia Oral Insulin Sales by Type (2018-2029)
9.1.2 Asia Oral Insulin Revenue by Type (2018-2029)
9.2 Asia Oral Insulin Market Size by Application
9.2.1 Asia Oral Insulin Sales by Application (2018-2029)
9.2.2 Asia Oral Insulin Revenue by Application (2018-2029)
9.3 Asia Oral Insulin Sales by Region
9.3.1 Asia Oral Insulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oral Insulin Revenue by Region (2018-2029)
9.3.3 Asia Oral Insulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Insulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Oral Insulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oral Insulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral Insulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Oral Insulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oral Insulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral Insulin Sales by Country
10.3.1 Middle East, Africa and Latin America Oral Insulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oral Insulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oral Insulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novo Nordisk Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Oramed Pharmaceuticals
11.2.1 Oramed Pharmaceuticals Company Information
11.2.2 Oramed Pharmaceuticals Overview
11.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Oramed Pharmaceuticals Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Oramed Pharmaceuticals Recent Developments
11.3 vTv Therapeutics
11.3.1 vTv Therapeutics Company Information
11.3.2 vTv Therapeutics Overview
11.3.3 vTv Therapeutics Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 vTv Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 vTv Therapeutics Recent Developments
11.4 Diabetology
11.4.1 Diabetology Company Information
11.4.2 Diabetology Overview
11.4.3 Diabetology Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Diabetology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Diabetology Recent Developments
11.5 Generex Biotechnology
11.5.1 Generex Biotechnology Company Information
11.5.2 Generex Biotechnology Overview
11.5.3 Generex Biotechnology Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Generex Biotechnology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Generex Biotechnology Recent Developments
11.6 Coromed
11.6.1 Coromed Company Information
11.6.2 Coromed Overview
11.6.3 Coromed Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Coromed Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Coromed Recent Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Information
11.7.2 Nektar Therapeutics Overview
11.7.3 Nektar Therapeutics Oral Insulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Nektar Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nektar Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Insulin Industry Chain Analysis
12.2 Oral Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Insulin Production Mode & Process
12.4 Oral Insulin Sales and Marketing
12.4.1 Oral Insulin Sales Channels
12.4.2 Oral Insulin Distributors
12.5 Oral Insulin Customers
13 Market Dynamics
13.1 Oral Insulin Industry Trends
13.2 Oral Insulin Market Drivers
13.3 Oral Insulin Market Challenges
13.4 Oral Insulin Market Restraints
14 Key Findings in The Global Oral Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type 1 Diabetes
Table 3. Major Manufacturers of Type 2 Diabetes
Table 4. Global Oral Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Oral Insulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Oral Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Oral Insulin Revenue Market Share by Region (2018-2024)
Table 9. Global Oral Insulin Revenue Market Share by Region (2024-2029)
Table 10. Global Oral Insulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Oral Insulin Sales by Region (2018-2024) & (K Units)
Table 12. Global Oral Insulin Sales by Region (2024-2029) & (K Units)
Table 13. Global Oral Insulin Sales Market Share by Region (2018-2024)
Table 14. Global Oral Insulin Sales Market Share by Region (2024-2029)
Table 15. Global Oral Insulin Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Oral Insulin Sales Share by Manufacturers (2018-2024)
Table 17. Global Oral Insulin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Oral Insulin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Oral Insulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Oral Insulin Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Oral Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Insulin as of 2022)
Table 23. Global Key Manufacturers of Oral Insulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral Insulin, Product Offered and Application
Table 25. Global Key Manufacturers of Oral Insulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 28. Global Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 29. Global Oral Insulin Sales Share by Type (2018-2024)
Table 30. Global Oral Insulin Sales Share by Type (2024-2029)
Table 31. Global Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Oral Insulin Revenue Share by Type (2018-2024)
Table 34. Global Oral Insulin Revenue Share by Type (2024-2029)
Table 35. Oral Insulin Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Oral Insulin Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 38. Global Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 39. Global Oral Insulin Sales Share by Application (2018-2024)
Table 40. Global Oral Insulin Sales Share by Application (2024-2029)
Table 41. Global Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Oral Insulin Revenue Share by Application (2018-2024)
Table 44. Global Oral Insulin Revenue Share by Application (2024-2029)
Table 45. Oral Insulin Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Oral Insulin Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Oral Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Oral Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Oral Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Oral Insulin Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Oral Insulin Sales by Country (2024-2029) & (K Units)
Table 60. Europe Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 61. Europe Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 62. Europe Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 65. Europe Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 66. Europe Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Oral Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Oral Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Oral Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Oral Insulin Sales by Country (2018-2024) & (K Units)
Table 72. Europe Oral Insulin Sales by Country (2024-2029) & (K Units)
Table 73. China Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 74. China Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 75. China Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 78. China Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 79. China Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 82. Asia Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 83. Asia Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 86. Asia Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 87. Asia Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Oral Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Oral Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Oral Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Oral Insulin Sales by Region (2018-2024) & (K Units)
Table 93. Asia Oral Insulin Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Oral Insulin Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Oral Insulin Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Oral Insulin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Oral Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral Insulin Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Oral Insulin Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Oral Insulin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Oral Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Oral Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral Insulin Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Oral Insulin Sales by Country (2024-2029) & (K Units)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Description and Major Businesses
Table 109. Novo Nordisk Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Novo Nordisk Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novo Nordisk Recent Developments
Table 112. Oramed Pharmaceuticals Company Information
Table 113. Oramed Pharmaceuticals Description and Major Businesses
Table 114. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Oramed Pharmaceuticals Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Oramed Pharmaceuticals Recent Developments
Table 117. vTv Therapeutics Company Information
Table 118. vTv Therapeutics Description and Major Businesses
Table 119. vTv Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. vTv Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. vTv Therapeutics Recent Developments
Table 122. Diabetology Company Information
Table 123. Diabetology Description and Major Businesses
Table 124. Diabetology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Diabetology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Diabetology Recent Developments
Table 127. Generex Biotechnology Company Information
Table 128. Generex Biotechnology Description and Major Businesses
Table 129. Generex Biotechnology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Generex Biotechnology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Generex Biotechnology Recent Developments
Table 132. Coromed Company Information
Table 133. Coromed Description and Major Businesses
Table 134. Coromed Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Coromed Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Coromed Recent Developments
Table 137. Nektar Therapeutics Company Information
Table 138. Nektar Therapeutics Description and Major Businesses
Table 139. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Nektar Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Nektar Therapeutics Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Oral Insulin Distributors List
Table 145. Oral Insulin Customers List
Table 146. Oral Insulin Market Trends
Table 147. Oral Insulin Market Drivers
Table 148. Oral Insulin Market Challenges
Table 149. Oral Insulin Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Insulin Product Picture
Figure 2. Global Oral Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Insulin Market Share by Type in 2022 & 2029
Figure 4. Type 1 Diabetes Product Picture
Figure 5. Type 2 Diabetes Product Picture
Figure 6. Global Oral Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oral Insulin Market Share by Application in 2022 & 2029
Figure 8. Female
Figure 9. Male
Figure 10. Oral Insulin Report Years Considered
Figure 11. Global Oral Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Oral Insulin Revenue 2018-2029 (US$ Million)
Figure 13. Global Oral Insulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Oral Insulin Revenue Market Share by Region (2018-2029)
Figure 15. Global Oral Insulin Sales 2018-2029 ((K Units)
Figure 16. Global Oral Insulin Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Oral Insulin Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Oral Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Oral Insulin Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Oral Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Oral Insulin Sales YoY (2018-2029) & (K Units)
Figure 22. China Oral Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Oral Insulin Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Oral Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Oral Insulin Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Oral Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Oral Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Oral Insulin in the World: Market Share by Oral Insulin Revenue in 2022
Figure 29. Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Oral Insulin Sales Market Share by Type (2018-2029)
Figure 31. Global Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 32. Global Oral Insulin Sales Market Share by Application (2018-2029)
Figure 33. Global Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Oral Insulin Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Oral Insulin Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Oral Insulin Revenue Share by Country (2018-2029)
Figure 39. US & Canada Oral Insulin Sales Share by Country (2018-2029)
Figure 40. U.S. Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Oral Insulin Sales Market Share by Type (2018-2029)
Figure 43. Europe Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 44. Europe Oral Insulin Sales Market Share by Application (2018-2029)
Figure 45. Europe Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 46. Europe Oral Insulin Revenue Share by Country (2018-2029)
Figure 47. Europe Oral Insulin Sales Share by Country (2018-2029)
Figure 48. Germany Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 49. France Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 53. China Oral Insulin Sales Market Share by Type (2018-2029)
Figure 54. China Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 55. China Oral Insulin Sales Market Share by Application (2018-2029)
Figure 56. China Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 57. Asia Oral Insulin Sales Market Share by Type (2018-2029)
Figure 58. Asia Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 59. Asia Oral Insulin Sales Market Share by Application (2018-2029)
Figure 60. Asia Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Oral Insulin Revenue Share by Region (2018-2029)
Figure 62. Asia Oral Insulin Sales Share by Region (2018-2029)
Figure 63. Japan Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 67. India Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Oral Insulin Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Oral Insulin Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Oral Insulin Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Oral Insulin Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Oral Insulin Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Oral Insulin Sales Share by Country (2018-2029)
Figure 74. Brazil Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Oral Insulin Revenue (2018-2029) & (US$ Million)
Figure 79. Oral Insulin Value Chain
Figure 80. Oral Insulin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries